Cameron John Reynolds - 26 Mar 2025 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Signature
/s/ Cameron John Reynolds
Issuer symbol
VNRX
Transactions as of
26 Mar 2025
Net transactions value
+$100,000
Form type
4
Filing time
27 Mar 2025, 08:13:46 UTC
Previous filing
31 Jan 2025
Next filing
19 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Purchase $100,000 +181,818 +8.6% $0.5500 2,299,222 26 Mar 2025 Direct F1
holding VNRX Common Stock 1,007,718 26 Mar 2025 By Concord International, Inc. F2
holding VNRX Common Stock 34,076 26 Mar 2025 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired at the offering price in the registered direct offering of Common Stock by VolitionRx.
F2 The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.